Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.

CD, Spinner; RL, Gottlieb; GJ, Criner; López JR, Arribas; AM, Cattelan; Viladomiu A, Soriano; O, Ogbuagu; P, Malhotra; KM, Mullane; A, Castagna; LYA, Chai; M, Roestenberg; OTY, Tsang; E, Bernasconi; Turnier P, Le; SC, Chang; D, SenGupta; RH, Hyland; AO, Osinusi; H, Cao; C, Blair; H, Wang; A, Gaggar; DM, Brainard; MJ, McPhail; S, Bhagani; MY, Ahn; AJ, Sanyal; G, Huhn; FM, Marty

doi:10.1001/jama.2020.16349

Public

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.

Shared by NobleBlocks on Sep 1, 2020 • 12:00 AM UTC

Authors:

Spinner CD

Gottlieb RL

Criner GJ

Abstract

Importance Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate disease is unknown.Objective To determine the efficacy of 5 or 10 days of remdesivir treatment compared with standar...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!